Abstract
Objectives
Contrast-enhanced harmonic endoscopic ultrasonography (CH-EUS) utilizes the second-harmonic signals from contrast microbubbles located in the vessels to improve the detectability of microcirculation. Many studies have used CH-EUS to stratify the malignancy risk of submucosal tumors (SMTs), discriminate gastrointestinal stromal tumors (GISTs) from benign SMTs, and predict the malignancy of GISTs based on the regularity of vessels or enhancing patterns. The aim of this study was to conduct a meta-analysis to evaluate the diagnostic performance of CH-EUS in the differential diagnosis of SMTs.
Methods
After searching the Medline, Embase, and Cochrane databases systematically, studies that evaluated the diagnostic accuracy of CH-EUS for the prediction of the malignancy potential of SMTs were pooled. The diagnostic accuracy was computed using a stochastic effect model. The overall test performance was summarized with the summary receiver operating characteristic curve.
Results
Six studies discriminated GISTs from benign lesions, and three studies discriminated low-risk from high-risk GISTs, covering a total of 354 cases of SMT. The overall accuracy of CH-EUS in predicting malignancy risk can be assessed as follows: sensitivity 0.87 (95% CI 0.82–0.91), specificity 0.82 (95% CI 0.74–0.89), positive likelihood ratio of 3.55 (95% CI 2.39–5.27), negative likelihood ratio of 0.21 (95% CI 0.13–0.33), and diagnostic odds ratio of 22.17 (95% CI 10.43–47.10). The overall area under the curve was 0.89. Subgroup analysis of the sensitivity and specificity for studies discriminating low-risk from high-risk GISTs were 0.93 (95% CI 0.77–0.99) and 0.81 (95% CI 0.63–0.93), respectively. There was evidence of significant heterogeneity, but no proof of publication bias.
Conclusions
CH-EUS is an effective tool for improving the diagnostic accuracy of conventional EUS for discriminating SMTs and is superior to other imaging techniques. However, due to the limited number of well-designed control studies, we should take into consideration the uncertainty of this method when altering a treatment plan.
Similar content being viewed by others
References
Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S et al (2018) Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29:iv267
Alkhatib AA, Faigel DO (2012) Endoscopic ultrasonography-guided diagnosis of subepithelial tumors. Gastrointest Endosc Clin N Am 22(187–205):vii
Zhang XC, Li QL, Yu YF, Yao LQ, Xu MD, Zhang YQ, Zhong YS, Chen WF, Zhou PH (2016) Diagnostic efficacy of endoscopic ultrasound-guided needle sampling for upper gastrointestinal subepithelial lesions: a meta-analysis. Surg Endosc 30:2431–2441
Yegin EG, Duman DG (2016) Small EUS-suspected gastrointestinal stromal tumors of the stomach: an overview for the current state of management. Endosc Ultrasound 5:69–77
Yamashita Y, Kato J, Ueda K, Nakamura Y, Abe H, Tamura T, Itonaga M, Yoshida T, Maeda H, Moribata K, Niwa T, Maekita T, Iguchi M, Tamai H, Ichinose M (2015) Contrast-enhanced endoscopic ultrasonography can predict a higher malignant potential of gastrointestinal stromal tumors by visualizing large newly formed vessels. J Clin Ultrasound 43:89–97
Kitano M, Yamashita Y (2017) New imaging techniques for endoscopic ultrasonography: contrast-enhanced endoscopic ultrasonography. Gastrointest Endosc Clin N Am 27:569–583
Alvarez-Sanchez MV, Napoleon B (2014) Contrast-enhanced harmonic endoscopic ultrasound imaging: basic principles, present situation and future perspectives. World J Gastroenterol 20:15549–15563
Lee HS, Cho CM, Kwon YH, Nam SY (2019) Predicting malignancy risk in gastrointestinal subepithelial tumors with contrast-enhanced harmonic endoscopic ultrasonography using perfusion analysis software. Gut Liver 13:161–168
Cho IR, Park JC, Roh YH, Choi SI, Lee JE, Kim EH, Shin SK, Lee SK, Lee YC (2019) Noninvasive prediction model for diagnosing gastrointestinal stromal tumors using contrast-enhanced harmonic endoscopic ultrasound. Dig Liver Dis 51:985–992
Kamata K, Takenaka M, Kitano M, Omoto S, Miyata T, Minaga K, Yamao K, Imai H, Sakurai T, Watanabe T, Nishida N, Chikugo T, Chiba Y, Imamoto H, Yasuda T, Lisotti A, Fusaroli P, Kudo M (2017) Contrast-enhanced harmonic endoscopic ultrasonography for differential diagnosis of submucosal tumors of the upper gastrointestinal tract. J Gastroenterol Hepatol 32:1686–1692
Ignee A, Jenssen C, Hocke M, Dong Y, Wang WP, Cui XW, Woenckhaus M, Iordache S, Saftoiu A, Schuessler G, Dietrich CF (2017) Contrast-enhanced (endoscopic) ultrasound and endoscopic ultrasound elastography in gastrointestinal stromal tumors. Endosc Ultrasound 6:55–60
Park HY, Jeon SW, Lee HS, Cho CM, Bae HI, Seo AN, Kweon OK (2016) Can contrast-enhanced harmonic endosonography predict malignancy risk in gastrointestinal subepithelial tumors? Endosc Ultrasound 5:384–389
Kannengiesser K, Mahlke R, Petersen F, Peters A, Ross M, Kucharzik T, Maaser C (2012) Contrast-enhanced harmonic endoscopic ultrasound is able to discriminate benign submucosal lesions from gastrointestinal stromal tumors. Scand J Gastroenterol 47:1515–1520
Zhao Y, Qian L, Li P, Zhang S (2016) The diagnostic value of endoscopic ultrasonography and contrast-enhanced harmonic endoscopic ultrasonography in gastrointestinal stromal tumors. Endosc Ultrasound 5:111–117
Sakamoto H, Kitano M, Matsui S, Kamata K, Komaki T, Imai H, Dote K, Kudo M (2011) Estimation of malignant potential of GI stromal tumors by contrast-enhanced harmonic EUS (with videos). Gastrointest Endosc 73:227–237
Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529–536
Yang Y, Li L, Qu C, Liang S, Zeng B, Luo Z (2016) Endoscopic ultrasound-guided fine needle core biopsy for the diagnosis of pancreatic malignant lesions: a systematic review and meta-analysis. Sci Rep 6:22978
Deville WL, Buntinx F, Bouter LM, Montori VM, de Vet HC, van der Windt DA, Bezemer PD (2002) Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2:9
Rosman AS, Korsten MA (2007) Application of summary receiver operating characteristics (sROC) analysis to diagnostic clinical testing. Adv Med Sci 52:76–82
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
Cui N-Y, Liu J-Y, Wang Y, Cai J-Q, Zou S-M, Wang YXJ (2016) Contrast enhanced ultrasound guided biopsy shows higher positive sampling rate than conventional ultrasound guided biopsy for gastrointestinal stromal tumors diagnosis. Transl Cancer Res 5:152–159
Shah P, Gao F, Edmundowicz SA, Azar RR, Early DS (2009) Predicting malignant potential of gastrointestinal stromal tumors using endoscopic ultrasound. Dig Dis Sci 54:1265–1269
Ji F, Wang ZW, Wang LJ, Ning JW, Xu GQ (2008) Clinicopathological characteristics of gastrointestinal mesenchymal tumors and diagnostic value of endoscopic ultrasonography. J Gastroenterol Hepatol 23:e318–324
Nomura N, Goto H, Niwa Y, Arisawa T, Hirooka Y, Hayakawa T (1999) Usefulness of contrast-enhanced EUS in the diagnosis of upper GI tract diseases. Gastrointest Endosc 50:555–560
Cui N-Y, Zhang R, Feng X-L, Zou S-M, Gu L-S, Gong X-T, Han J, Wang Y, Lv K (2017) The value of pre- and post-contrast-enhanced ultrasound in evaluation of malignant potential of gastrointestinal stromal tumors. Transl Cancer Res 6:1088–1096
Stock K, Hann von Weyhern C, Slotta-Huspenina J, Burian M, Clevert DA, Meining A, Prinz C, Pachmann C, Holzapfel K, Schmid RM, Lersch C (2010) Microcirculation of subepithelial gastric tumors using contrast-enhanced ultrasound. Clin Hemorheol Microcirc 45:225–232
Fukuta N, Kitano M, Maekawa K, Chikugo T, Kudo M (2005) Estimation of the malignant potential of gastrointestinal stromal tumors: the value of contrast-enhanced coded phase-inversion harmonics US. J Gastroenterol 40:247–255
Zhuang H, Zhang M, Lei L, Zhang Q, Li Z, Xia L, Luo Y (2013) Diagnostic value of intraluminal contrast enhanced ultrasonography in evaluation of gastrointestinal stromal tumors. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 30:493–498
Chhoda A, Jain D, Surabhi VR, Singhal S (2018) Contrast enhanced harmonic endoscopic ultrasound: a novel approach for diagnosis and management of gastrointestinal stromal tumors. Clin Endosc 51:215–221
Dietrich CF, Jenssen C, Hocke M, Cui XW, Woenckhaus M, Ignee A (2012) Imaging of gastrointestinal stromal tumours with modern ultrasound techniques—a pictorial essay. Z Gastroenterol 50:457–467
Lee TH (2018) Can contrast-enhanced harmonic endoscopic ultrasonography differentiate malignancy from benign disease? Clin Endosc 51:5–7
Kim M, Jung H, Choi KD, Song HJ, Lee JH, Kim DH, Choi K, Lee GH, Kim J (2011) Natural history of asymptomatic small gastric subepithelial tumors. J Clin Gastroenterol 45:330–336
Kim MN, Kang SJ, Kim SG, Im JP, Kim JS, Jung HC, Song IS (2013) Prediction of risk of malignancy of gastrointestinal stromal tumors by endoscopic ultrasonography. Gut Liver 7:642–647
Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56:1129–1135
Sidhu P, Cantisani V, Dietrich C, Gilja O, Saftoiu A, Bartels E, Bertolotto M, Calliada F, Clevert D-A, Cosgrove D (2018) The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (long version). Ultraschall Medizin 39:e2–e44
Fusaroli P, Kypraios D, Mancino MG, Spada A, Benini MC, Bianchi M, Bocus P, De Angelis C, De Luca L, Fabbri C, Grillo A, Marzioni M, Reggio D, Togliani T, Zanarini S, Caletti G (2012) Interobserver agreement in contrast harmonic endoscopic ultrasound. J Gastroenterol Hepatol 27:1063–1069
Acknowledgements
This study was supported by grants from the Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment Open Project Fund (cstc2018jxjl0276) and Fundamental Research Funds for the Central Universities (2019CDYGYB018). No other financial relationships relevant to this publication were disclosed.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Yong-tao Yang, Neng Shen, Fei Ao, Wei-qing Chen have no conflicts of interest or financial ties to disclose.
Ethical approval
The study was approved by the Research Ethics Committee of Chongqing University Cancer Hospital.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Yang, Yt., Shen, N., Ao, F. et al. Diagnostic value of contrast-enhanced harmonic endoscopic ultrasonography in predicting the malignancy potential of submucosal tumors: a systematic review and meta-analysis. Surg Endosc 34, 3754–3765 (2020). https://doi.org/10.1007/s00464-020-07585-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-020-07585-6